LoginSignup
Arrowhead Pharms logo

Arrowhead Pharms

Stock
Stock
ISIN: US04280A1007
Ticker: ARWR
US04280A1007
ARWR

Price

Price

Frequently asked questions

What is Arrowhead Pharms's market capitalization?

The market capitalization of Arrowhead Pharms is $2.30B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Arrowhead Pharms?

Arrowhead Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$4.651. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Arrowhead Pharms's stock?

Currently, 15 analysts cover Arrowhead Pharms's stock, with a consensus target price of $52.43. Analyst ratings provide insights into the stock's expected performance.

What is Arrowhead Pharms's revenue over the trailing twelve months?

Over the trailing twelve months, Arrowhead Pharms reported a revenue of $19.65M.

What is the EBITDA for Arrowhead Pharms?

Arrowhead Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$529.76M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Arrowhead Pharms?

Arrowhead Pharms has a free cash flow of -$531.98M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Arrowhead Pharms's stock?

The 5-year beta for Arrowhead Pharms is 0.81. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Arrowhead Pharms have, and what sector and industry does it belong to?

Arrowhead Pharms employs approximately 525 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Arrowhead Pharms's shares?

The free float of Arrowhead Pharms is 118.76M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.30B

5Y beta

 0.81

EPS (TTM)

 -$4.651

Free Float

 118.76M

Revenue (TTM)

 $19.65M

EBITDA (TTM)

 -$529.76M

Free Cashflow (TTM)

 -$531.98M

Pricing

1D span
$18.19$18.86
52W span
$17.05$39.83

Analyst Ratings

The price target is $52.43 and the stock is covered by 15 analysts.

Buy

9

Hold

6

Sell

0

Information

Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 14 clinical-stage investigational medicines (nine wholly owned and five partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MUC5AC, ARO-MMP7, GSK-4532990, Fazirsiran, JNJ-3989, HZN-457, ARO-C3, ARO-PNPLA3, ARO-DUX4 and ARO-SOD1.

525

Biotechnology & Drugs

Health Care

Identifier

ISIN

US04280A1007

Primary Ticker

ARWR

Knockouts

Join the conversation
Sign upLogin